AstraZeneca PLC Ordinary Shares (AZN)

Capital Expenditure

-$5.07B

TTM · Period ending: · USD

AZN logo

AZN Capital Expenditure

Latest reported-$5.07B
AZN TTM CapEx (-$636.08M → -$5.07B)
High-resolution chart · PNG

AZN capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AstraZeneca PLC Ordinary Shares Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-5,070,379,684
-6,240,529,051
-5,671,529,051
-5,573,000,000
-5,205,000,000
-3,950,000,000
-4,586,000,000
-4,577,000,000
-4,098,000,000
-3,913,000,000
-3,778,000,000
-3,386,000,000
-3,618,000,000
-3,678,000,000
-2,571,000,000
-2,735,000,000
-2,284,000,000
-2,029,000,000
-2,135,000,000
-1,965,000,000
-2,010,000,000
-2,699,000,000
-2,606,000,000
-2,443,000,000
-2,079,000,000
-2,076,000,000
-2,460,000,000
-2,484,000,000
-2,412,000,000
-1,797,000,000
-1,371,000,000
-1,513,000,000
-1,597,000,000
-1,569,000,000
-1,620,000,000
-1,710,000,000
-1,723,000,000
-2,393,000,000
-2,314,000,000
-2,208,000,000
-2,376,000,000
-2,019,000,000
-2,788,000,000
-2,722,000,000
-2,603,000,000
-3,099,000,000
-2,752,000,000
-3,069,000,000
-3,128,000,000
-2,372,000,000
-2,058,000,000
-1,836,000,000
-4,934,000,000
-4,831,000,000
-4,619,000,000
-4,433,000,000
-1,105,000,000
-1,228,000,000
-1,297,000,000
-1,192,000,000
-663,000,000
-1,224,000,000
-2,112,000,000
-3,796,000,000
-4,537,000,000
-3,832,000,000
-2,957,000,000
-1,493,000,000
-1,338,000,000
-1,385,000,000
-4,039,000,000
-4,017,000,000
-4,169,000,000
-4,212,000,000
-1,679,000,000
-1,493,000,000
-1,390,000,000
-1,455,000,000
-1,339,000,000
-1,141,000,000
-1,065,000,000
-867,000,000
-810,000,000
-1,661,000,000
-834,000,000
-1,285,000,000
-1,063,000,000
-125,000,000
-678,000,000
-10,000,000
0
0
0
-350,161,091
-635,603,002
-635,603,002
-997,603,002
-936,200,146
-994,640,262
-994,640,262
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.